相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combination of dabrafenib plus trametinib for BRAF and MEK inhibitor pretreated patients with advanced BRAFV600-mutant melanoma: an open-label, single arm, dual-centre, phase 2 clinical trial
Max Schreuer et al.
LANCET ONCOLOGY (2017)
Treatment patterns of advanced malignant melanoma (stage III-IV) - A review of current standards in Europe
Mark Harries et al.
EUROPEAN JOURNAL OF CANCER (2016)
Prognostic markers and tumour growth kinetics in melanoma patients progressing on vemurafenib
Heike Seifert et al.
MELANOMA RESEARCH (2016)
BRAFV600E Kinase Domain Duplication Identified in Therapy-Refractory Melanoma Patient-Derived Xenografts
Kristel Kemper et al.
CELL REPORTS (2016)
Tunable-Combinatorial Mechanisms of Acquired Resistance Limit the Efficacy of BRAF/MEK Cotargeting but Result in Melanoma Drug Addiction
Gatien Moriceau et al.
CANCER CELL (2015)
Intra- and inter-tumor heterogeneity in a vemurafenib-resistant melanoma patient and derived xenografts
Kristel Kemper et al.
EMBO MOLECULAR MEDICINE (2015)
Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy
Claudia Wellbrock et al.
PIGMENT CELL & MELANOMA RESEARCH (2015)
The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma
Rachel Ramsdale et al.
SCIENCE SIGNALING (2015)
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state
Annelien Verfaillie et al.
NATURE COMMUNICATIONS (2015)
MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment
Stefanie Riesenberg et al.
NATURE COMMUNICATIONS (2015)
The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma
Rachel Ramsdale et al.
SCIENCE SIGNALING (2015)
JUNB Is a Key Transcriptional Modulator of Macrophage Activation
Mary F. Fontana et al.
JOURNAL OF IMMUNOLOGY (2015)
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
Chong Sun et al.
NATURE (2014)
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Ophir Shalem et al.
SCIENCE (2014)
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
Judith Mueller et al.
NATURE COMMUNICATIONS (2014)
Efficacy of Intermittent Combined RAF and MEK Inhibition in a Patient with Concurrent BRAF- and NRAS-Mutant Malignancies
Omar Abdel-Wahab et al.
CANCER DISCOVERY (2014)
A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors
David J. Konieczkowski et al.
CANCER DISCOVERY (2014)
Intermittent dosing with vemurafenib in BRAF V600E-mutant melanoma: review of a case series
Andrew J. Dooley et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2014)
Continued Response Off Treatment After BRAF Inhibition in Refractory Hairy Cell Leukemia
Sascha Dietrich et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
Meghna Das Thakur et al.
NATURE (2013)
Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis
Liesbeth C. W. Vredeveld et al.
GENES & DEVELOPMENT (2012)
Conversion from the oncogene addiction to drug addiction by intensive inhibition of the EGFR and MET in lung cancer with activating EGFR mutation
Kenichi Suda et al.
LUNG CANCER (2012)
Successful rechallenge in two patients with BRAF-V600-mutant melanoma who experienced previous progression during treatment with a selective BRAF inhibitor
Amelie Clementine Seghers et al.
MELANOMA RESEARCH (2012)
ERK2 but Not ERK1 Induces Epithelial-to-Mesenchymal Transformation via DEF Motif-Dependent Signaling Events
Sejeong Shin et al.
MOLECULAR CELL (2010)
Cancer stem cells versus phenotype-switching in melanoma
Keith S. Hoek et al.
PIGMENT CELL & MELANOMA RESEARCH (2010)
In vivo switching of human melanoma cells between proliferative and invasive states
Keith S. Hoek et al.
CANCER RESEARCH (2008)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
LA Garraway et al.
NATURE (2005)
分享论文
